Show simple item record

dc.contributor.authorKeiser, Olivia*
dc.contributor.authorTweya, Hannock*
dc.contributor.authorBoulle, Andrew*
dc.contributor.authorBraitstein, Paula*
dc.contributor.authorSchecter, Mauro*
dc.contributor.authorBrinkhof, Martin W G*
dc.contributor.authorDabis, François*
dc.contributor.authorTuboi, Suely*
dc.contributor.authorSprinz, Eduardo*
dc.contributor.authorPujades-Rodriguez, Mar*
dc.contributor.authorCalmy, Alexandra*
dc.contributor.authorKumarasamy, Nagalingeswaran*
dc.contributor.authorNash, Denis*
dc.contributor.authorJahn, Andreas*
dc.contributor.authorMacPhail, Patrick*
dc.contributor.authorLüthy, Ruedi*
dc.contributor.authorWood, Robin*
dc.contributor.authorEgger, Matthias*
dc.date.accessioned2011-01-31T14:57:52Z
dc.date.available2011-01-31T14:57:52Z
dc.date.issued2009-09-10
dc.identifier.citationSwitching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. 2009, 23 (14):1867-74 AIDSen
dc.identifier.issn1473-5571
dc.identifier.pmid19531928
dc.identifier.doi10.1097/QAD.0b013e32832e05b2
dc.identifier.urihttp://hdl.handle.net/10144/120708
dc.description.abstractIn high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia.
dc.language.isoenen
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAntiretroviral Therapy, Highly Activeen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshDeveloping Countriesen
dc.subject.meshDrug Monitoringen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHIV Protease Inhibitorsen
dc.subject.meshHIV-1en
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMedically Underserved Areaen
dc.subject.meshMiddle Ageden
dc.subject.meshReverse Transcriptase Inhibitorsen
dc.subject.meshTime Factorsen
dc.subject.meshTreatment Failureen
dc.subject.meshViral Loaden
dc.subject.meshYoung Adulten
dc.titleSwitching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.en
dc.contributor.departmentInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.en
dc.identifier.journalAIDS (London, England)en
refterms.dateFOA2019-03-04T08:38:37Z
html.description.abstractIn high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia.


Files in this item

Thumbnail
Name:
Keiser_switching_AIDS_09.pdf
Size:
365.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record